Researchers Develop New Nanotechnology to Detect Disease Biomarkers

Wake Forest Baptist researchers have developed a new technology to detect disease biomarkers in the form of nucleic acids.
According to the report on News Medical:

In the new technique, nanotechnology is used to determine whether a specific target nucleic acid sequence exists within a mixture, and to quantify it if it does through a simple electronic signature.

Adam R. Hall, Ph.D., assistant professor of biomedical engineering at Wake Forest Baptist commented:

If the sequence you are looking for is there, it forms a double helix with a probe we provide and you see a clear signal. If the sequence isn’t there, then there isn’t any signal. By simply counting the number of signals, you can determine how much of the target is around.

Click here to view the full press release.